We send the latest information from SMC Laboratories.
Study published in Sci Transl Med. on the effects of A monoclonal antibody targeting nonjunctional claudin-1 in CKD of UUO model.
We introduce a case study of drug efficacy evaluation of anti-claudin-1 antibody using our chronic kidney dise…
READ MORE
Study published in Cells. on the effects of ameliorating epigenetic modifications by ATP1A1 signalosome inhibition in the liver cancer of STAM™ mice
SMC is proud to announce that Marshall University (WV) has published the results of their study using our pre-…
READ MORE
【New Preclinical Data】 The effects of Il-18 inhibitor on cholangitis and liver fibtrosis in DDC-induced primary sclerosing cholangitis (PSC) model mice
We are pleased to announce that our client AprilBio Co., Ltd. (KOR) published the results of preclinical studi…
READ MORE
SMC will present study at the American Association for the Study of Liver Diseases (AASLD) Liver Meeting
We will be presenting our study on STAM™ mice at the American Association for the Study of Liver Disease…
READ MORE
Study published in Biomed Pharmacother. on the effects of GRP119 agonist in the treatment of NASH in STAM™ mice
SMC is proud to announce that Dong-A ST Co., Ltd. (KOR) has published the results of their study using our pre…
READ MORE
Study published in Front Immunol. on co-occurrence of non-alcoholic steatohepatitis exacerbates psoriasis in STAM™
We are pleased to introduce a study on non-alcoholic steatohepatitis (NASH) may promote the development and ex…
READ MORE
【Publication Archive】 Study focusing on iron metabolism and mitophagy for the treatment of NASH and HCC published in EMBO Rep.
Please take a look at published study focusing on intracellular iron metabolism and mitophagy as therapeutic t…
READ MORE
89bio Inc. and SMC’s presentation at EASL Congress 2023 in Vienna, Austria!
SMC announced that our client’s 89bio Inc. (CA/ISR)will present results of a study using STAM™ mic…
READ MORE
AprilBio Co., Ltd., and SMC’s presentation at EASL Congress 2023 in Vienna, Austria!
SMC announced that our client’s AprilBio Co., Ltd., (KOR) will present results of a study using STAM&tra…
READ MORE
Our article was published in Nature Brand magazine (Biopharma Dealmakers)!
It's about the concept of metabolic-associated fatty liver disease (MAFLD) and how we work with it, which…
READ MORE